GlassScriptPhysician profile
Christopher A Rupe
NPI 1740401249
$4,393.31
in general payments reported to CMS, 2019-2025
27 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.37 · 2020: $533 · 2021: $132 · 2022: $562 · 2023: $166 · 2024: $2,737 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $1,127 · Travel and Lodging: $448 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $1,127.36 |
| Travel and Lodging | $448.44 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,482.99 | 2024 | |
| Bard Peripheral Vascular, INC. | $417.27 | 2020-2021 | |
| Endologix LLC | $312.80 | 2022 | |
| Lemaitre Vascular, INC. | $237.77 | 2019-2025 | Artegraft Vascular Graft |
| Smith+Nephew, INC. | $206.74 | 2019-2025 | Grafix Pl, Stravix Pl, Grafix |
| Inari Medical, INC. | $124.43 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $76.41 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Davol INC. | $72.78 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $55.76 | 2021-2025 | Myrisk |
| Zimmer Biomet Holdings, INC. | $37.81 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $34.71 | 2022-2023 | Seglentis |
| Allergan, INC. | $33.04 | 2019-2020 | |
| Organogenesis INC. | $28.84 | 2025 | Affinity |
| Osiris Therapeutics INC. | $25.71 | 2019 | |
| Silk Road Medical, INC. | $24.00 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $23.85 | 2025 | |
| Rti Surgical, INC | $23.61 | 2024 | |
| Abbvie INC. | $20.47 | 2023 | Dalvance |
| Ambu INC. | $19.75 | 2022 | |
| Angiodynamics, INC. | $19.23 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.67 | 2025 | |
| Kerecis Limited | $18.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Innocoll Pharmaceuticals Limited | $18.27 | 2022 | |
| Solventum Corporation | $17.50 | 2025 | Prevena |
| Leica Microsystems INC. | $17.00 | 2023 | Neoprobe |
| Kci USA, INC. | $14.11 | 2021 | |
| Tactile Systems Technology INC | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rupe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.